（As of September 2021）
Development Pipelines
| Product code | Target Indication | Dosage Form | Development region | Current Phase |
|---|---|---|---|---|
| M5120B | Superficial skin infection and Acne vulgaris | Topical | JP | Jan, 2021 Approval |
| M7040B | Scalp eczema dermatitis | Topical | JP | Feb, 2021 Approval |
| M1220 | Rosacea | Topical | JP | Filed for Approval |
| M5250 | Pruritus with atopic dermatitis (adults) *PIII studies in progress for pediatric |
Injection | JP | Filed for Approval |
| M6060 | Primary axillary hyperhidrosis | Topical | JP | Filed for Approval |
| M1210 | Ingrown nails | Topical | JP | PIII |
| M5220B | Recurrent herpes simplex | Oral | JP | PIII |
| M5250B | Pruritus with prurigo nodularis | Injection | JP | PIII |
| M6050E | Acne vulgaris | Topical | JP | PIII |
| M1880C | Prurigo nodularis | Topical | JP | PII |
| M6050C | Acne vulgaris | Topical | JP | PII |
- Product List
- Product Pipeline
- Business Partnerships
- Product Activities